These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Oral steroid contraception in hyperprolactinemia (author's transl)]. Völker W, Reitmann I, Kannengiesser U, Niesert S, Gehring WG, von zur Mühlen A. Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):199-203. PubMed ID: 7215761 [Abstract] [Full Text] [Related]
3. Incidence of hyperprolactinemia during oral contraceptive therapy. Reyniak JV, Wenof M, Aubert JM, Stangel JJ. Obstet Gynecol; 1980 Jan; 55(1):8-11. PubMed ID: 7352067 [Abstract] [Full Text] [Related]
4. [Amenorrhea and the pill]. Verdino P, Viard R, Harter M. Lyon Mediterr Med Med Sud Est; 1983 Jan; 19(2):7067-74. PubMed ID: 12279701 [Abstract] [Full Text] [Related]
15. Review: oral contraceptives and menopausal estrogens in relation to breast neoplasia. Brzezinski A, Schenker JG. Isr J Med Sci; 1982 Apr; 18(4):433-8. PubMed ID: 7045033 [Abstract] [Full Text] [Related]
17. Case control study finds long-term pill use is associated with higher risk of benign liver tumors. Int Fam Plann Dig; 1976 Jun; 2(2):13-5. PubMed ID: 12334249 [Abstract] [Full Text] [Related]